SCHEMBL5131591

SCHEMBL5131591

O=C(O)COCCNCS(=O)(=O)c1ccc(Cl)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 1/20 0.38
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HTT P42858 2/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 3/20 0.35
MMP8 P22894 2/20 0.35
MMP12 P39900 2/20 0.35
MMP13 P45452 2/20 0.35
ALDH1A1 P00352 2/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 2/20 0.34
PSEN1 P49768 2/20 0.33
PSEN2 P49810 2/20 0.33
APH1B Q8WW43 2/20 0.33
NCSTN Q92542 2/20 0.33
APH1A Q96BI3 2/20 0.33
PSENEN Q9NZ42 2/20 0.33
HTR1A P08908 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493229 0.77 ALDH1A1 (0.42) P2RY2KMT2AHTTALDH1A1
SCHEMBL493617 0.76 KMT2A (0.42) P2RY2KMT2AALDH1A1PKMLMNA
SCHEMBL5114277 0.75 ALDH1A1 (0.40) KMT2ASMN1; SMN2HTTALDH1A1POLB
SCHEMBL5128116 0.75 ALDH1A1 (0.49) KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL493564 0.74 TDP1 (0.36) P2RY2KMT2AMEN1TSHRLMNA
SCHEMBL5125393 0.73 KMT2A (0.39) P2RY2KMT2AHTTTSHRALDH1A1
SCHEMBL493087 0.73 TDP1 (0.43) P2RY2TSHRALDH1A1LMNA
SCHEMBL493498 0.72 TBXA2R (0.46) KMT2AMEN1MMP8MMP13ALDH1A1
SCHEMBL5131594 0.72 NPC1 (0.44) KMT2ASMN1; SMN2HTTTSHRMAPT
SCHEMBL4464905 0.72 WDR5 (0.39) P2RY2KMT2AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580965-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-11-12 US disclosed
US-20080249128-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249128-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, NPSR1 P2RY2 89/4885KMT2A 2892/4885MEN1 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.